Johnson & Johnson MedTech | Electrophysiology

Let's learn from the experts using the WADL approach for Ventricular Tachycardia (VT). Next week, join Drs. Timothy Maher, Andre d'Avila, Andrew Locke and Shu Yang as they outline their mapping and ablation techniques in the treatment of VT. Register here: https://bit.ly/4iIc5pb #EPeeps

Join us and elevate your LAAO workflow with faculty Ashok Chaudhary, MD. Gain a comprehensive understanding of best practices and key workflows utilizing NUVISION™ 4D ICE in structural heart procedures. 📅 Course highlights: - In-depth platform overview of the NUVISION™ 4D ICE catheter - Stepwise approach to integrating the NUVISION™ ultrasound catheter into your practice - Focus on safe and effective use of 4D imaging for LAAO Register now: https://bit.ly/4bu2iRi #EPeeps #LAAO

At Johnson & Johnson MedTech, we're driven by a relentless passion to push healthcare forward. The EP Fellows Masterclass provides early career EPs with an immersive learning experience designed to elevate your skills with the CARTO™ 3 system. Ready to take your career to the next level? Sign up now and join us for this transformative event! https://bit.ly/3Fj6mYB #EPeeps #MedicalEducation #JNJMedTech

Join us for an intensive exploration of Ventricular Tachycardia (VT) at our comprehensive 1.5-day program in Chicago, IL, on June 21-22. This course, led by course directors Drs. Henry Huang and Jeffery Winterfield, combines engaging lectures with real-world case presentations to provide a deep dive into clinically relevant ablation strategies. *This course is intended for EP fellows and early-career EP's.    Register here: https://bit.ly/3XrYgTP #EPeeps

We're excited to see how UK #EPeeps leverage this technology for complex cases! 💓

At Johnson & Johnson MedTech, we are committed to delivering innovative products around the treatment of atrial fibrillation (AFib). We are excited to join colleagues and other industry experts at this year's #WAFib2025. See you in Salt Lake City!

It takes a team to navigate someone’s atrial fibrillation (AFib) journey. After seeking a second opinion on treatment options, renowned sports broadcaster Mike “Greeny” Greenberg’s doctor addressed the efficacy and safety of cardiac catheter ablation. Within a month, Mike received a referral to the electrophysiology department and completed the procedure. The best part about the procedure? Mike was home day-of and began recovery journey! #HeartMonth #GetSmartAboutAFib #EPeeps Learn more about cardiac catheter ablation: https://bit.ly/4ey2xeF

We are excited to join our partners and colleagues at #ISLAA25. Stop by and engage with our team to learn more about the latest in our ICE portfolio. #LAAO #EPeeps #Inteventioncardiology

The QDOT MICRO™ Catheter is our latest generation innovation in focal RF ablation designed to provide temperature control through automatic adjustment of power and fluid output based on real-time temperature measurement, which includes: ➡️ Advanced, high-energy ablation ➡️ Improved temperature monitoring* (1,2) ➡️ Optimized irrigation ** (3) ➡️ High signal resolution At Johnson & Johnson MedTech, we are committed to optimizing tools for electrophysiologists treating atrial fibrillation (AFib). Learn more about our next generation RF ablation catheter: https://bit.ly/3WwBoBf US_BWI_THER_392661 * Based on a multicenter single arm study n=52. Improved temperature monitoring compared to traditional STSF catheter design with a single thermocouple. **When compared to THERMOCOOL SMARTTOUCH(R) Catheter and THERMOCOOL SMARTTOUCH(R) SF Catheter 1. Reddy, V. Y. et al (2019). Pulmonary Vein Isolation With Very High Power, Short Duration, Temperature-Controlled Lesions: The QDOT-FAST Trial. JACC. Clinical electrophysiology, 5(7), 778–786. 2. Leshem, E. et al (2018). High-Power and Short-Duration Ablation for Pulmonary Vein Isolation: Biophysical Characterization. JACC. Clinical electrophysiology, 4(4), 467–479. 3. Reddy VY, Grimaldi M, De Potter T, et al. Pulmonary Vein Isolation With Very High Power, Short Duration, Temperature-Controlled Lesions: The QDOT-FAST Trial. JACC Clin Electrophysiol. 2019;5(7):778-786.

At Johnson & Johnson MedTech, we are committed to delivering innovative products around the treatment of atrial fibrillation (AFib). The QDOT MICRO ™ Catheter is our latest generation RF ablation catheter designed to provide optimized temperature control through automatic adjustment of power and fluid output based on real-time temperature measurement* (1,2). It allows for advanced, high-power ablation, improved temperature monitoring* (1,2), optimized irrigation** (3), and higher signal resolution. Learn more about the QDOT MICRO™ Catheter: https://bit.ly/3WwBoBf US_BWI_THER_392660 *Based on a multicenter single arm study n=52. Improved temperature monitoring compared to traditional STSF catheter design with a single thermocouple. ** When compared to THERMOCOOL SMARTTOUCH(R) Catheter and THERMOCOOL SMARTTOUCH(R) SF Catheter 1. Leshem E, Zilberman I, Tschabrunn CM, Barkagan M, Contreras-Valdes FM et al. (2018) High-power and short-duration ablation for pulmonary vein isolation: biophysical characterization. 4 (4): 467-479. 2. Reddy VY, Grimaldi M, De Potter T, Vijgen JM, Bulava A et al. (2019) Pulmonary Vein Isolation with Very High Power–Short Duration Temperature-Controlled Lesions: The First-in-Human QDOT-FAST Multicenter Trial. JACC: Clinical Electrophysiology 3. Reddy VY, Grimaldi M, De Potter T, et al. Pulmonary Vein Isolation With Very High Power, Short Duration, Temperature-Controlled Lesions: The QDOT-FAST Trial. JACC Clin Electrophysiol. 2019;5(7):778-786.